Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival.

Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF.

Surgery. 2006 Dec;140(6):891-7; discussion 897-8.

PMID:
17188135
2.

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.

Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA.

Cancer J. 2003 Jul-Aug;9(4):261-7.

PMID:
12967136
3.

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.

Cancer. 2005 Oct 15;104(8):1590-602.

4.

Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.

Søreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V, Bergan A, Flatmark A.

Surgery. 1992 Jan;111(1):48-54.

PMID:
1728075
5.

Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.

Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM.

J Am Coll Surg. 2007 Mar;204(3):372-82.

PMID:
17324770
6.

Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.

Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S.

Am J Clin Oncol. 2009 Dec;32(6):574-81. doi: 10.1097/COC.0b013e31819cca35.

PMID:
19636238
7.

Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.

Nykjaer KM, Grønbaek H, Nielsen DT, Christiansen P, Astrup LB.

In Vivo. 2007 Jul-Aug;21(4):679-84.

8.
9.

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.

PMID:
18847650
10.

Long-term survival after resection for primary hepatic carcinoid tumor.

Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW.

Ann Surg Oncol. 2003 Dec;10(10):1171-5. Review.

PMID:
14654473
11.

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Hellman P, Lundström T, Ohrvall U, Eriksson B, Skogseid B, Oberg K, Tiensuu Janson E, Akerström G.

World J Surg. 2002 Aug;26(8):991-7. Epub 2002 May 21.

PMID:
12016480
12.

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.

Surgery. 2007 Mar;141(3):330-9. Epub 2006 Nov 1.

PMID:
17349844
13.

Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.

Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN.

J Gastrointest Surg. 2007 Jan;11(1):66-72.

PMID:
17390189
14.

Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer.

Evans MD, Escofet X, Karandikar SS, Stamatakis JD.

World J Surg Oncol. 2009 Mar 10;7:28. doi: 10.1186/1477-7819-7-28.

15.

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.

Er O, Frye DK, Kau SW, Broglio K, Valero V, Hortobagyi GN, Arun B.

Cancer J. 2008 Jan-Feb;14(1):62-8. doi: 10.1097/PPO.0b013e3181629a7b.

PMID:
18303485
16.

Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.

Jensen EH, Kvols L, McLoughlin JM, Lewis JM, Alvarado MD, Yeatman T, Malafa M, Shibata D.

Ann Surg Oncol. 2007 Feb;14(2):780-5. Epub 2006 Dec 5.

PMID:
17146740
17.

Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.

Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, D'Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N.

Ann Surg Oncol. 2009 Jul;16(7):1844-51. doi: 10.1245/s10434-009-0348-1. Epub 2009 Feb 18.

PMID:
19224284
18.

[Malignant tumors of the small intestine].

Kelm C, Padberg W, Zimmermann T, Hürtgen M, Buhr J.

Zentralbl Chir. 1994;119(9):639-44. German.

PMID:
7526578
19.

Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.

Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D'Angelica M, Fong Y, Blumgart LH, DeMatteo RP.

J Am Coll Surg. 2007 Aug;205(2):231-8. Epub 2007 Jun 27.

PMID:
17660069
20.

Pulmonary resection of colorectal metastases in patients with or without a history of hepatic metastases.

Joosten J, Bertholet J, Keemers-Gels M, Barendregt W, Ruers T.

Eur J Surg Oncol. 2008 Aug;34(8):895-9. doi: 10.1016/j.ejso.2008.01.009. Epub 2008 Feb 15.

PMID:
18280692

Supplemental Content

Support Center